Congestive heart failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
The aim of this article is to report a case of CCF after the endoscopic resection of a growth hormone secreting pituitary microadenoma, and to discuss and review all the cases of CCF secondary to transsphenoidal procedures described in literature.
|
31712112 |
2020 |
Congestive heart failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
This article appraises the current evidence regarding growth hormone and testosterone deficiencies in HF and reviews novel findings about the treatment of these conditions in HF.
|
31079696 |
2019 |
Congestive heart failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
Combined effects of growth hormone and testosterone replacement treatment in heart failure.
|
31696666 |
2019 |
Congestive heart failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
Growth Hormone Therapy in Heart Failure.
|
30266359 |
2018 |
Congestive heart failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
Interestingly, GH replacement therapy represents a possible future therapeutic option in CHF.
|
29153202 |
2018 |
Congestive heart failure
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Clinical trials also indicate that in CHF patients with low insulin-like growth factor-1 or low thyroid hormone levels, supplemental treatment with growth hormone or thyroid hormone seems to be cardioprotective; and in CHF patients with volume overload the vasopressin antagonists can relieve the symptoms superior to loop diuretics.
|
29468912 |
2018 |
Congestive heart failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
Decreased anabolism because of alterations in the insulin-like growth factor 1 (IGF-1)/growth hormone (GH) axis and increased catabolism induced by proinflammatory cytokines like tumor necrosis factor α (TNF-α) and interleukin 6 (IL-6) have been reported to contribute to muscle wasting in chronic heart failure (CHF).
|
28695463 |
2017 |
Congestive heart failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
In this study, we evaluated the effects of GH on soleus muscle and cardiac remodeling in rats with aortic stenosis (AS)-induced HF.
|
29137319 |
2017 |
Congestive heart failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
Although mounting evidence supports the concept that growth hormone (GH) deficiency (GHD) affects cardiovascular function, no study has systematically investigated its prevalence and role in a large cohort of chronic heart failure (CHF) patients.
|
28095492 |
2017 |
Congestive heart failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
Acromegaly is a pathological condition associated with excess growth hormone (GH) and insulin-like growth factor-I (IGF-I) and a high prevalence of diabetes, hypertension, atherosclerosis, and heart failure; resulting in premature death.
|
22370764 |
2012 |
Congestive heart failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
Decreased GH, decreased IGF-I and increased MMP-9 activities may be possible diagnostic markers in RHD for developing heart failure.
|
16406300 |
2006 |
Congestive heart failure
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We hypothesized that local myocardial overexpression of GH could prevent ventricular remodeling and heart failure following myocardial infarction (MI) in rats.
|
15081312 |
2004 |
Congestive heart failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
We tested the hypothesis that GH could improve cardiac and renal function in volume overload-induced heart failure.
|
11799079 |
2002 |
Congestive heart failure
|
0.100 |
Biomarker
|
disease |
BEFREE |
GH effects were examined at early (4 months) and late (10 months) phases of disease in the cardiomyopathic (CM) hamster, and the combination of GH with chronic ACE inhibition was assessed in late-phase heart failure.
|
10525494 |
1999 |